Company Data
Aptorum Group Limited
Ticker
APM
Current Price
$1.0951 -1.34%
Market Cap
$5.7M
Price Target
Refer to Report
Volume
34.1K
52wk Range
$0.46 - $17.49
Overview
Aptorum Group Ltd clinical-stage biopharmaceutical company. It is engaged in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. The company operates in two segments: Therapeutics and Non-Therapeutics. Its lead projects are ALS-4, SACT-1, and RPIDD. It is also engaged in providing healthcare services.